Carpenter, Thomas
2317  results:
Search for persons X
?
 
?
4

OR13-2 Characterizing the Impact of Burosumab on Bone Healt..:

Carpenter, Thomas ; Cassinelli, Hamilton ; Glorieux, Francis...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A191-A192 , 2022
 
?
5

OR13-1 Long-Term Burosumab Therapy Provides Sustained Benef..:

Carpenter, Thomas ; Cimms, Tricia ; Hetzer, Joel...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A191-A191 , 2022
 
?
8

Bench‐to‐bedside translation of chimeric antigen receptor (..:

Singh, Aman P. ; Chen, Wenbo ; Zheng, Xirong...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  4 - p. 362-376 , 2021
 
?
11

Development of a minimal physiologically-based pharmacokine..:

Jiang, Xiling ; Chen, Xi ; Jaiprasart, Pharavee...
European Journal of Pharmaceutical Sciences.  146 (2020)  - p. 105260 , 2020
 
?
12

OR13-1 Burosumab Improves the Biochemical, Skeletal, and Cl..:

Jan De Beur, Suzanne ; Miller, Paul ; Weber, Thomas...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
?
13

OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxyma..:

Wolf, Myles ; Rubin, Janet ; Achebe, Maureen...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
?
 
1-15